Finance

Lists
Why is AT20 down 2.44%?
Dive Deeper
AT20:FRA
Atara Biotherapeutics Inc
€8.00
-2.44%
(-0.20) 1D
Oct 19, 3:38:05 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AT20...
Open
€8.05
High
€8.05
Low
€8.00
Mkt. cap
92.10M
Avg. vol.
7.00
Volume
0.00
52-wk high
€16.30
52-wk low
€3.48
No. of employees
10
Open
€8.05
High
€8.05
Low
€8.00
Mkt. cap
92.10M
Avg. vol.
7.00
Volume
0.00
52-wk high
€16.30
52-wk low
€3.48
No. of employees
10
News stories
From web sources and news partners
About Atara Biotherapeutics Inc
CEO-
Employees10
Founded2012
HeadquartersThousand Oaks, California, United States
SectorBiotechnology
Websiteatarabio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.45M
1.60M
516.00K
630.00K
Cost of goods sold
3.02M
783.00K
288.00K
1.54M
Cost of revenue
3.02M
783.00K
288.00K
1.54M
Research and development expenses
-
2.86M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.98M
3.47M
3.60M
3.05M
Operating expense
3.98M
6.33M
3.60M
3.05M
Total operating expenses
7.00M
7.11M
3.88M
4.58M
Operating income
-3.55M
-5.52M
-3.37M
-3.95M
Other non operating income
4.00K
-49.00K
-
-
EBT including unusual items
-4.28M
-3.41M
-4.14M
-4.83M
EBT excluding unusual items
-4.25M
-6.36M
-4.14M
-4.07M
Income tax expense
28.00K
-
-
1.00K
Effective tax rate
-0.65%
-
-
-0.02%
Other operating expenses
-
-
-
-
Net income
-4.30M
-3.41M
-4.14M
-4.83M
Net profit margin
-124.62%
-213.54%
-803.29%
-767.30%
Earnings per share
-0.32
-0.35
-0.29
-0.32
Interest and investment income
204.00K
100.00K
54.00K
78.00K
Interest expense
-909.00K
-894.00K
-830.00K
-191.00K
Net interest expenses
-705.00K
-794.00K
-776.00K
-113.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.19M
-4.47M
-3.34M
-3.94M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps